Lv0
0 积分 2021-11-11 加入
Liver Tumor Microenvironment
6天前
已完结
Liver Tumor Microenvironment
6天前
已关闭
中国药物性肝损伤基层诊疗与管理指南（2024年）
19天前
已完结
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
1个月前
已关闭
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E
1个月前
已完结
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D
1个月前
已完结
1676PD - Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma
1个月前
已关闭
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
1个月前
已关闭
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
3个月前
已完结
Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials
3个月前
已完结
皖公网安备34019202002308
